Key result
The Israeli Blood Pressure Control program improved blood pressure control from 29% at baseline to 46.4% at 1 year among hypertensive patients, demonstrating potential cost-effectiveness.
Why the study?
Does the Israeli Blood Pressure Control (IBPC) program improve risk factor control and provide cost utility in hypertensive patients?
Population
4,948 hypertensive patients, mean age 64.8 +/- 12 years, 42% male, from 30 general practice clinics in Israel.
Comparison
Israeli Blood Pressure Control program vs Baseline (pre-intervention)
Design
Cohort
Follow-up
1 year
Authors
Loading...
May support structured primary care BP programs; leaves open confirmation of cost savings in randomized trials.
Observational (n=4,948)
Yes
Does the Israeli Blood Pressure Control (IBPC) program improve risk factor control and provide cost utility in hypertensive patients?
Absolute Event Rate: 46.4% vs 29%
A general practitioner-led intervention program to enhance risk factor control in hypertensive patients significantly improved BP, LDL, and BMI targets, and is projected to be cost-saving.
Yosefy et al. (2003) conducted an observational in Hypertension (n=4,948). Israeli Blood Pressure Control (IBPC) program vs. Baseline (pre-intervention) was evaluated on Blood pressure control. The Israeli Blood Pressure Control program improved blood pressure control from 29% at baseline to 46.4% at 1 year among hypertensive patients, demonstrating potential cost-effectiveness.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: